切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - D3 Receptors - cannabinoid receptor - Voltage-gated Sodium (NaV) Channels - Animal Experiments

14件产品中的 1-10

页面
每页
清除全部
  1. Quinidine
    B7590 Quinidine
    中文名: 奎尼丁
    Target: Voltage-gated Sodium (NaV) Channels|Cytochrome P450 (CYP450)
    Summary: 降低Na+和K+通道电流
      ≥11.95 mg/mL
      insoluble in H2O
  2. Bupivacaine HCl
    B1420 Bupivacaine HCl
    中文名: 盐酸布比卡因
    Target: Voltage-gated Sodium (NaV) Channels
    Summary: 麻醉药
      ≥10.25 mg/mL
      ≥16.23 mg/mL
  3. Phenytoin sodium
    B2272 Phenytoin sodium
    中文名: 苯妥英钠
    Target: Voltage-gated Sodium (NaV) Channels
    Summary: 钠通道稳定剂
      ≥11.55 mg/mL
      insoluble in H2O
  4. Pramipexole
    B1488 Pramipexole
    中文名: 普拉克索
    Target: D2 Receptors|D3 Receptors|D4 Receptors
    Summary: 多巴胺激动剂
      ≥10.57 mg/mL
      insoluble in H2O
  5. Proparacaine HCl
    B2274 Proparacaine HCl
    中文名: 盐酸丙美卡因
    Target: Voltage-gated Sodium (NaV) Channels
    Summary: 电压门控钠通道拮抗剂
      ≥14.9 mg/mL
      ≥17.73 mg/mL
  6. GW842166X
    B1428 GW842166X
    Target: cannabinoid receptor
    Summary: 大麻素受体激动剂
      Soluble in DMSO
  7. Quetiapine Fumarate
    B1490 Quetiapine Fumarate
     1 Citation
    中文名: 富马酸奎硫平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺受体拮抗剂
      ≥11.03 mg/mL
      insoluble in H2O
  8. Clozapine
    B2235 Clozapine
    中文名: 氯氮平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|D4 Receptors
    Summary: 5-HT受体拮抗剂
      ≥14.95 mg/mL
      insoluble in H2O
  9. A-803467
    B2277 A-803467
    Target: Voltage-gated Sodium (NaV) Channels
    Summary: NaV1.8通道阻断剂
      ≥13.95 mg/mL
      insoluble in H2O
  10. Thioridazine HCl
    A8537 Thioridazine HCl
    中文名: 盐酸硫利达嗪,盐酸硫代利哒,甲硫达嗪盐酸盐,甲硫哒嗪盐酸盐
    Target: Cytochrome P450 (CYP450)|D1 and D5 Receptors|D2 Receptors|D3 Receptors|D4 Receptors
    Summary: 钙通道蛋白抑制剂
      ≥20.35 mg/mL
      ≥6.78 mg/mL

14件产品中的 1-10

页面
每页